Want to join the conversation?
Maker of genetic pharmaceutical products $LCI said that its President, Michael J. Bogda, is resigning from the company, effective June 3, 2016, to pursue other interests. CEO Arthur Bedrosian said that Mr. Bogda spearheaded the integration of $LCI's two most recent acquisitions, Kremers Urban Pharmaceuticals and Silarx Pharmaceuticals.
Does anyone feel $SBUX CEO Schultz stepping down could prove a disaster for the company?
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.